Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses

Journal of Experimental Medicine

Volumn 188, Issue 8, 1998, Pages 1453-1464

  Kouskoff, Valerie ^a   Famiglietti, Sara ^a   Lacaud, Georges ^a   Lang, Paul ^c   Rider, James E ^d   Kay, Brian K ^e   Cambier, John C ^a,b   Nemazee, David ^a,d,f  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

B lymphocytes; Differential activation; Immunoglobulin; Phage library; Transgenic mice

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 6; LIGAND; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; ANTIGENS, CD40; B-LYMPHOCYTES; CALCIUM; CELLS, CULTURED; CYTOKINES; ENZYME PRECURSORS; H-2 ANTIGENS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; T-LYMPHOCYTES;

EID: 0032547805     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.8.1453     Document Type: Article

References (63)

1. Nossal, G.J. 1995. Choices following antigen entry: antibody formation or immunologic tolerance? Annu. Rev. Immunol. 13:1-27.
2. Lam, K.P., R. Kuhn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 90:1073-1083.
3. Cyster, J.G., J.I. Healy, K. Kishihara, T.W. Mak, M.L. Thomas, and C.C. Goodnow. 1996. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature. 381:325-328.
4. Gu, H., D. Tarlinton, W. Muller, K. Rajewsky, and I. Forster. 1991. Most peripheral B cells in mice are ligand selected. J. Exp. Med. 173:1357-1371.
5. Ma, A., P. Fisher, R. Dildrop, E. Oltz, G. Rathbun, P. Achacoso, A. Stall, and F.W. Alt. 1992. Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines. EMBO (Eur. Mol. Biol. Organ.) J. 11:2727-2734.
6. Cambier, J.C., and J.G. Monroe. 1984. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies. J. Immunol. 133: 576-581.
7. DeFranco, A.L., E.S. Raveche, and W.E. Paul. 1985. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies. J. Immunol. 135:87-94.
8. Goroff, D.K., A. Stall, J.J. Mond, and F.D. Finkelman. 1986. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-δ antibodies. I. Determinants of B lymphocyte-activating properties. J. Immunol. 136:2382-2392.
9. Hamano, T., and R. Asofsky. 1983. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation. J. Immunol. 130:2027-2032.
10. Maruyama, S., H. Kubagawa, and M.D. Cooper. 1985. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-μ antibodies. J. Immunol. 135:192-199.
11. Mongini, P.K., C.A. Blessinger, and J.P. Dalton. 1991. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands. J. Immunol. 146:1791-1800.
12. Rudich, S.M., R. Winchester, and P.K. Mongini. 1985. Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies. J. Exp. Med. 162:1236-1255.
13. Cambier, J.C., C.M. Pleiman, and M.R. Clark. 1994. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:457-486.
14. Reth, M., and J. Wienands. 1997. Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol. 15:453-479.
15. Pleiman, C.M., C. Abrams, L.T. Gauen, W. Bedzyk, J. Jongstra, A.S. Shaw, and J.C. Cambier. 1994. Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc. Natl. Acad. Sci. USA. 91: 4268-4272.
16. Clark, E.A., and J.A. Ledbetter. 1994. How B and T cells talk to each other. Nature. 367:425-428.
17. Chan, A.C., and A.S. Shaw. 1996. Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr. Opin. Immunol. 8:394-401.
18. Alberola, I.J., S. Takaki, J.D. Kerner, and R.M. Perlmutter. 1997. Differential signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 15:125-154.
19. DeFranco, A.L. 1997. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:296-308.
20. Healy, J.I., R.E. Dolmetsch, L.A. Timmerman, J.G. Cyster, M.L. Thomas, G.R. Crabtree, R.S. Lewis, and C.C. Goodnow. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:419-428.
21. Kurosaki, T. 1997. Molecular mechanisms in B cell antigen receptor signaling. Curr. Opin. Immunol. 9:309-318.
22. Law, C.L., A. Craxton, K.L. Otipoby, S.P. Sidorenko, S.J. Klaus, and E.C. Clark. 1996. Regulation of signalling through B-lymphocyte antigen receptors by cell-cell interaction molecules. Immunol. Rev. 153:123-154.
23. Monroe, J.G. 1996. Tolerance sensitivity of immature-stage B cells: can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role? J. Immunol. 156:2657-2660.
24. Bachmann, M.F., U.H. Rohrer, T.M. Kundig, K. Burki, H. Hengartner, and R.M. Zinkernagel. 1993. The influence of antigen organization on B cell responsiveness. Science. 262: 1448-1451.
25. Dintzis, H.M., R.Z. Dintzis, and B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA. 73: 3671-3675.
26. Mond, J.J., A. Lees, and C.M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
27. Batista, F.D., and M.S. Neuberger. 1998. Affinity dependence of the B cell response to antigen: a threshold, a ceiling and the importance of off-rate. Immunity. 8:751-759.
28. Goodnow, C.C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA. 93:2264-2271.
29. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 252:1308-1310.
30. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H.M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. .Annu. Rev. Immunol. 12:413-431.
31. Evavold, B.D., L.J. Sloan, and P.M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today. 14:602-609.
32. Fremont, D.H., W.A. Rees, and H. Kozono. 1996. Biophysical studies of T-cell receptors and their ligands. Curr. Opin. Immunol. 8:93-100.
33. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
34. De Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analogmajor histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625-634.
35. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
36. Russell, D.M., Z. Dembic, G. Morahan, J.F. Miller, K. Burki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature. 354:308-311.
37. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009-1020.
38. Sparks, A.B., L.A. Quilliam, J.M. Thorn, C.J. Der, and B.K. Kay. 1994. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J. Biol. Chem. 269:23853-23856.
39. Messing, J. 1983. New M13 vectors for cloning. Methods Enzymol. 101:20-78.
40. Sparks, A.B., N.B. Adey, L.A. Quilliam, J.M. Thorn, and B.K. Kay. 1995. Screening phage-displayed random peptide libraries for SH3 ligands. Methods Enzymol. 255:498-509.
41. Lin, T.C., R.E. Webster, and W. Konigsberg. 1980. Isolation and characterization of the C and D proteins coded by gene IX and gene VI in the filamentous bacteriophage fl and fd. J. Biol. Chem. 255:10331-10337.
42. Justement, L.B., J. Kreiger, and J.C. Cambier. 1989. Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig. J. Immunol. 143:881-889.
43. Toellner, K.M., A. Gulbranson-Judge, D.R. Taylor, D.M. Sze, and I.C. MacLennan. 1996. Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J. Exp. Med. 183:2303-2312.
44. Tosato, G., J. Tanner, K.D. Jones, M. Revel, and S.E. Pike. 1990. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 64:3033-3041.
45. Schena, M., G. Gaidano, D. Gottardi, F. Malavasi, L.G. Larsson, K. Nilsson, and F. Caligaris-Cappio. 1992. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. Leukemia. 6:120-125.
46. Pang, Y., Y. Norihisa, D. Benjamin, R.R. Kantor, and H.A. Young. 1992. Interferon-γ gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood. 80:724-732.
47. Kindler, V., T. Matthes, P. Jeannin, and R.H. Zubler. 1995. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking. Eur. J. Immunol. 25:1239-1243.
48. Katano, M., T. Morisaki, T. Matsuo, M. Nakamura, E. Kubota, and T. Hisatsugu. 1994. Interleukin-2 (IL-2) production by human B-cell line. Cell Immunol. 159:262-270.
49. Lenschow, D.J., A.I. Sperling, M.P. Cooke, G. Freeman, L. Rhee, D.C. Decker, G. Gray, L.M. Nadler, C.C. Goodnow, and J.A. Bluestone. 1994. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1990-1997.
50. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
51. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209-1213.
52. Nemazee, D.A. 1987. Proceedings of the EMBO Workshop on Tolerance. P. Matzinger, M. Flajlnik, D.A. Nemazee, H.-G. Rammensee, G. Stockinger, T. Rolink, and L. Nicklin, editors. 2:52-54.
53. Berridge, M.J. 1993. Inositol trisphosphate and calcium signalling. Nature. 361:315-325.
54. Hertz, M.W., V. Kouskoff, T. Nakamura, and D. Nemazee. 1998. V(D)J recombinase induction in splenic lymphocytes is inhibited by antigen receptor signaling. Nature. In press.
55. Matsui, K., J.J. Boniface, P. Steffner, P.A. Reay, and M.M. Davis. 1994. Kinetics of T-cell receptor binding to peptide/ I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA. 91:12862-12866.
56. Valitutti, S., and A. Lanzavecchia. 1997. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today. 18:299-304.
57. Lyons, D.S., S.A. Lieberman, J. Hampl, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:53-61.
58. Spanopoulou, E. 1996. Cellular and molecular analysis of lymphoid development using Rag-deficient mice. Int. Rev. Immunol. 13:257-288.
59. Ozato, K., N. Mayer, and D.H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533-540.
60. Schellekens, G.A., E. Lasonder, M. Feijlbrief, D.G. Koedijk, J.W. Drijfhout, A.J. Scheffer, S. Welling-Wester, and G.W. Welling. 1994. Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library. Eur. J. Immunol. 24:3188-3193.
61. Kay, B.K., N.B. Adey, Y.S. He, J.P. Manfredi, A.H. Mataragnon, and D.M. Fowlkes. 1993. An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. Gene (Amst.). 128:59-65.
62. Hoess, R.H., A.J. Mack, H. Walton, and T.M. Reilly. 1994. Identification of a structural epitope by using a peptide library displayed on filamentous bacteriophage. J. Immunol. 153:724-729.
63. Devlin, J.J., L.C. Panganiban, and P.E. Devlin. 1990. Random peptide libraries: a source of specific protein binding molecules. Science. 249:404-406.